冈林等人对重症监护病房中弥散性血管内凝血患者的止血标志物及脓毒症相关器官功能衰竭评估评分的评论 - Suppr | 超能文献

Comment on hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit by Okabayashi et al.

作者信息

Zeerleder Sacha, Voves Claudia, Wuillemin Walter A

出版信息

Am J Hematol. 2005 Aug;79(4):344. doi: 10.1002/ajh.20343.

DOI:10.1002/ajh.20343

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Comment on hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit by Okabayashi et al.冈林等人对重症监护病房中弥散性血管内凝血患者的止血标志物及脓毒症相关器官功能衰竭评估评分的评论

Am J Hematol. 2005 Aug;79(4):344. doi: 10.1002/ajh.20343.

2

Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit.重症监护病房中弥散性血管内凝血患者的止血标志物与脓毒症相关器官功能衰竭评估评分

Am J Hematol. 2004 Jul;76(3):225-9. doi: 10.1002/ajh.20089.

3

International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.国际血栓与止血学会显性弥散性血管内凝血评分可预测脓毒症患者的器官功能障碍和死亡率。

Blood Coagul Fibrinolysis. 2006 Sep;17(6):445-51. doi: 10.1097/01.mbc.0000240916.63521.2e.

4

Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.血清血栓调节蛋白水平与脓毒症患者的弥散性血管内凝血、多器官功能障碍综合征的临床病程及死亡率相关。

Crit Care Med. 2008 Mar;36(3):683-9. doi: 10.1097/CCM.0B013E31816537D8.

5

Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.组织因子途径抑制剂和 P 选择素作为脓毒症诱导的非显性弥漫性血管内凝血的标志物。

Clin Appl Thromb Hemost. 2011 Feb;17(1):80-7. doi: 10.1177/1076029609344981. Epub 2009 Aug 18.

6

Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.根据日本急性医学协会标准诊断的弥散性血管内凝血的临床病程及转归：脓毒症与创伤的比较

Thromb Haemost. 2008 Dec;100(6):1099-105.

7

High mobility group B1 levels in sepsis and Disseminated Intravascular Coagulation.脓毒症和弥散性血管内凝血中高迁移率族蛋白B1水平

Acta Biochim Pol. 2012;59(4):561-6. Epub 2012 Oct 23.

8

Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit.活化部分凝血活酶时间波形分析在外科重症监护病房患者脓毒症及显性弥散性血管内凝血识别中的应用

Crit Care Med. 2004 Feb;32(2):520-4. doi: 10.1097/01.CCM.0000110678.52863.F3.

9

Soluble thrombomodulin: a sign of bad times.可溶性血栓调节蛋白：不祥之兆。

Crit Care Med. 2008 Mar;36(3):985-7. doi: 10.1097/CCM.0B013E318165FDA7.

10

Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis.简易动态弥散性血管内凝血评分对严重脓毒症患者的预后价值

Crit Care Med. 2005 Oct;33(10):2214-21. doi: 10.1097/01.ccm.0000181296.53204.de.

引用本文的文献

1

Biological relevance of Granzymes A and K during sepsis.粒细胞酶 A 和 K 在脓毒症中的生物学相关性。

Theranostics. 2021 Oct 17;11(20):9873-9883. doi: 10.7150/thno.59418. eCollection 2021.